X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4748) 4748
Publication (744) 744
Newspaper Article (93) 93
Book Review (48) 48
Book Chapter (44) 44
Dissertation (10) 10
Conference Proceeding (7) 7
Magazine Article (4) 4
Book / eBook (3) 3
Data Set (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3100) 3100
humans (2938) 2938
chemokines (2569) 2569
female (1763) 1763
immunology (1759) 1759
animals (1674) 1674
cytokines (1642) 1642
male (1573) 1573
inflammation (1506) 1506
mice (1222) 1222
adult (1057) 1057
middle aged (1016) 1016
research (938) 938
expression (932) 932
research article (895) 895
gene expression (829) 829
medicine (822) 822
proteins (763) 763
lymphocytes (683) 683
multidisciplinary sciences (672) 672
health aspects (632) 632
immune system (628) 628
science (625) 625
cell biology (601) 601
infections (570) 570
chemokine cxcl10 - blood (561) 561
aged (560) 560
immune response (560) 560
dendritic cells (550) 550
rodents (540) 540
chemokine (518) 518
interferon (516) 516
t-cells (500) 500
mice, inbred c57bl (499) 499
cells, cultured (484) 484
analysis (473) 473
ligands (472) 472
pathogenesis (467) 467
disease (466) 466
activation (463) 463
physiological aspects (445) 445
infectious diseases (438) 438
biology (435) 435
chemokines - metabolism (424) 424
t cells (418) 418
article (412) 412
genetic aspects (411) 411
macrophages (406) 406
lymphocytes t (398) 398
signal transduction (398) 398
cells (397) 397
chemokine cxcl10 (397) 397
enzyme-linked immunosorbent assay (395) 395
cancer (392) 392
studies (381) 381
chemokine cxcl10 - metabolism (377) 377
care and treatment (373) 373
infection (371) 371
flow cytometry (365) 365
oncology (355) 355
biomarkers - blood (352) 352
gene-expression (352) 352
cxcl10 protein (350) 350
ifn-gamma (350) 350
development and progression (341) 341
immunity (340) 340
apoptosis (335) 335
young adult (331) 331
biomarkers (327) 327
adolescent (326) 326
interferon-gamma (322) 322
chemokine receptors (321) 321
case-control studies (315) 315
cytokines - metabolism (314) 314
medicine, research & experimental (314) 314
mice, knockout (307) 307
medical research (304) 304
biochemistry & molecular biology (303) 303
neurosciences (303) 303
disease models, animal (300) 300
antigens (295) 295
microbiology (294) 294
pathology (294) 294
cxcl10 (293) 293
in-vivo (293) 293
ip-10 (293) 293
viruses (288) 288
central-nervous-system (287) 287
virology (284) 284
angiogenesis (282) 282
chemokine cxcl10 - genetics (282) 282
respiratory system (282) 282
tumor necrosis factor-tnf (282) 282
patients (277) 277
kinases (266) 266
risk factors (262) 262
recruitment (258) 258
biology and life sciences (253) 253
monocytes (250) 250
nf-kappa-b (249) 249
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4849) 4849
Chinese (18) 18
Russian (7) 7
Japanese (5) 5
Portuguese (4) 4
Spanish (3) 3
Italian (2) 2
Polish (2) 2
Czech (1) 1
French (1) 1
Korean (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Investigation, ISSN 0021-9738, 01/2011, Volume 121, Issue 1, pp. 308 - 317
Chronic infection with hepatitis C virus (HCV) is a major public health problem, with nearly 170 million infected individuals worldwide Current treatment for... 
MEDICINE, RESEARCH & EXPERIMENTAL | LIVER INFLAMMATION | GAMMA-INDUCIBLE PROTEIN-10 | VIRUS-INFECTION | DIPEPTIDYL-PEPTIDASE-IV | ANTIVIRAL THERAPY | INSULIN-RESISTANCE | IMMUNE-RESPONSES | CHRONIC HEPATITIS-C | LEVELS CORRELATE | PEGINTERFERON PLUS RIBAVIRIN | Chemokine CXCL10 - blood | Prognosis | Antiviral Agents - therapeutic use | Receptors, CXCR3 - blood | Humans | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Chemokine CXCL10 - antagonists & inhibitors | Dipeptidyl Peptidase 4 - blood | Hepatitis C, Chronic - virology | Hepatitis C, Chronic - therapy | Recombinant Proteins | Hepatitis C, Chronic - blood | Polyethylene Glycols - therapeutic use | T-Lymphocytes - virology | Treatment Failure | Hepatitis C, Chronic - immunology | Peptide Fragments - blood | Protein Array Analysis | T-Lymphocytes - immunology | Proteases | Physiological aspects | Research | Diagnosis | Hepatitis C | Drug therapy | Chemokines | Hepatitis C, Chronic/therapy | T-Lymphocytes/immunology | Polyethylene Glycols/therapeutic use | Dipeptidyl Peptidase 4/blood | Receptors, CXCR3/blood | Chemokine CXCL10/blood | T-Lymphocytes/virology | Hepatitis C, Chronic/blood | Interferon-alpha/therapeutic use | Chemokine CXCL10/antagonists & inhibitors | Life Sciences | Immunology | Antiviral Agents/therapeutic use | Hepatitis C, Chronic/immunology | Peptide Fragments/blood | Ribavirin/therapeutic use | Hepatitis C, Chronic/virology
Journal Article
Diabetes, ISSN 0012-1797, 10/2009, Volume 58, Issue 10, pp. 2285 - 2291
Journal Article
Arthritis & rheumatology (Hoboken, N.J.), ISSN 2326-5191, 10/2015, Volume 67, Issue 10, pp. 2713 - 2722
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2013, Volume 8, Issue 12, p. e81329
Journal Article
Circulation Research, ISSN 0009-7330, 02/2015, Volume 116, Issue 5, pp. 876 - 883
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, p. e0133236
Serum levels of the interferon (IFN)-stimulated chemokine CXCL10 are increased during chronic HCV infection and associate with outcome of IFN-based therapy.... 
VIRUS-INFECTION | CHEMOKINES | MULTIDISCIPLINARY SCIENCES | CHRONIC HEPATITIS-C | PROTEIN-10 | GENOTYPE 1 INFECTION | PREDICTIVE-VALUE | RIBAVIRIN | INDUCTION | ASSOCIATION | SPONTANEOUS CLEARANCE | Recurrence | Interferons | Humans | Fluorenes - therapeutic use | Dipeptidyl Peptidase 4 - blood | Hepatitis C, Chronic - virology | Male | Adult | Female | Hepacivirus - physiology | Drug Therapy, Combination | Benzimidazoles - therapeutic use | Hepacivirus - drug effects | Sofosbuvir - therapeutic use | Virus Replication - drug effects | Chemokine CXCL10 - blood | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Dipeptidyl Peptidase 4 - genetics | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Hepatitis C, Chronic - blood | Convalescence | Chemokine CXCL10 - genetics | Protein Processing, Post-Translational | Hepatitis C, Chronic - genetics | Viral Load - drug effects | Infection | Care and treatment | Analysis | Interferon | Biological response modifiers | Hepatitis C virus | Health aspects | Therapy | Laboratories | Chronic infection | Critical care | Amino acids | Infections | Ribavirin | Clinical outcomes | Proteins | Genotype & phenotype | Hepatitis | Immunology | Hepatology | Post-translation | Pretreatment | Drug dosages | Genotypes | Statistical analysis | Liver diseases | Dendritic cells | Serum levels | Studies | Infectious diseases | CXCL10 protein | Biomarkers | Chemokines | Virus Replication/drug effects | Viral Load/drug effects | Dipeptidyl Peptidase 4/blood | Dipeptidyl Peptidase 4/genetics | Chemokine CXCL10/blood | Hepatitis C, Chronic/blood | Life Sciences | Hepatitis C, Chronic/drug therapy | Hepatitis C, Chronic/virology | Hepatitis C, Chronic/genetics | Chemokine CXCL10/genetics | Benzimidazoles/therapeutic use | Hepacivirus/physiology | Fluorenes/therapeutic use | Antiviral Agents/therapeutic use | Sofosbuvir/therapeutic use | Hepacivirus/drug effects | Ribavirin/therapeutic use
Journal Article
Arthritis Research and Therapy, ISSN 1478-6354, 02/2017, Volume 19, Issue 1, p. 20
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 5, pp. 7384 - 7390
Journal Article